Federal Circuit Strikes Down D.C. Pharmaceutical Law

Law360 (August 2, 2007, 12:00 AM EDT) -- A District of Columbia law that regulates the prices of patented drugs was struck down Wednesday by an appellate court, which ruled that the law is superseded by the federal government's exclusive power to legislate patents.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit, upholding a district court's ruling, ruled that federal patent law preempts the D.C. ordinance. The court cited the clause in the eighth section of Article I of the U.S. Constitution that grants, it said, sole authority over...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.